Ipragliflozin is a selective sodium glucose cotransporter 2 (SGLT2) inhibitor that increases urinary glucose excretion by inhibiting renal glucose reabsorption and thereby causes a subsequent antihyper-glycemic effect.
Molecular Weight:
519.58
Purity:
>99.0%
CAS Number:
[951382-34-6]
Formula:
C21H21FO5S.C5H9NO2
Target:
SGLT
* VAT and and shipping costs not included. Errors and price changes excepted
